2006
DOI: 10.1002/hep.21049
|View full text |Cite
|
Sign up to set email alerts
|

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

Abstract: Virus-specific CD8؉ T cell responses play an important role in the natural course of infection; however, the impact of certain CD8؉ T cell responses in determining clinical outcome has not been fully defined. A well-defined cohort of women inoculated with HCV from a single source showed that HLA-B27 has a strong association with spontaneous clearance. The immunological basis for this association is unknown. However, the finding is especially significant because HLA-B27 has also been shown to have a protective … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
192
1
4

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 194 publications
(209 citation statements)
references
References 38 publications
11
192
1
4
Order By: Relevance
“…Together with few other HLA class I molecules of the B locus, the HLA-B27 is associated with long-term non-progression to AIDS in patients, called 'elite controllers', which maintain a low viral load and remain asymptomatic for longer [50]. Furthermore, recent studies have revealed in HLA-B27 subjects a high rate of spontaneous clearance of hepatitis C virus [48,51]. The reasons for this are not completely understood, although virological and immunological explanations have been anticipated.…”
Section: Hla-b27 a Molecule With Two Faces: Protection From Viral Inmentioning
confidence: 99%
“…Together with few other HLA class I molecules of the B locus, the HLA-B27 is associated with long-term non-progression to AIDS in patients, called 'elite controllers', which maintain a low viral load and remain asymptomatic for longer [50]. Furthermore, recent studies have revealed in HLA-B27 subjects a high rate of spontaneous clearance of hepatitis C virus [48,51]. The reasons for this are not completely understood, although virological and immunological explanations have been anticipated.…”
Section: Hla-b27 a Molecule With Two Faces: Protection From Viral Inmentioning
confidence: 99%
“…Furthermore, when we expanded the dataset to include all available HCV sequences (including sequences with Ͻ90% sequence coverage), HLA-B*2705-associated viral polymorphisms at positions NS5B-2841 and 2846 were detected for genotype 1a, which fall within a described epitope 20 (Table 3). Two HLA-associated viral polymorphisms for genotype 3a fall within previously described epitopes, including the overlapping site at NS3-1444, which falls within the NS3-1436 epitope restricted by HLA-A*0101, where the consensus sequence is identical to that in genotype 1a (Fig.…”
Section: Hla-associated Viral Polymorphisms Within the Nonstructural mentioning
confidence: 99%
“…Carriage of the restricting HLA allele was associated with viral polymorphisms at several sites within immunogenic epitopes, consistent with viral escape from HLA-restricted immune pressure. At multiple sites, including experimentally established viral escape sites (for example, NS3-1397-1398 for HLA-B*0801 and NS5B-2841 and 2846 for HLA-B*2705 20,[23][24][25], there was nearly complete conservation in the alternative genotype, even in individuals carrying the relevant HLA alleles (Fig. 2).…”
Section: Amino Acid Variation Within Published and Predicted Viral Epmentioning
confidence: 99%
“…During acute PUUV infection, the kinetics of the PUUV-specific tetramer-positive T cells and the PUUV-specific T cells that produced IFN-c in vitro were sharply different (19). CTL causes either pathology or virus control, possibly due to differences in viral proteins (5), HLA haplotypes (12), and altered efficiency of T-cell responses as a consequence of heterologous immunity (15), but only few CTL epitopes restricted by HLA-A1, A2.1, and B51 have been identified for HTNV (8,20), which limited the investigation of protective or pathologic immune responses against HTNV infection. In this article, we screened a panel of overlapping peptides spanning the sequence of the HTNV nucleocapsid protein for those that can stimulate IFN-c responses by ex vivo ELISPOT, and then determined the HLA context of the T-cell responses by in vitro ELISPOT.…”
mentioning
confidence: 99%